Physician profile
Sarah E Hagarty
NPI 1790894897
$4,258.09
in general payments reported to CMS, 2019-2025
18 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $345 · 2022: $1,395 · 2023: $271 · 2024: $1,728 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $701 · Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.50 |
| Food and Beverage | $231.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,213.94 | 2021-2025 | |
| Allergan, INC. | $1,390.90 | 2021-2023 | |
| Smith+Nephew, INC. | $178.82 | 2019-2022 | |
| Sientra, INC. | $51.67 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $50.38 | 2021 | |
| Amgen INC. | $49.55 | 2021-2022 | |
| Mentor Worldwide LLC | $48.35 | 2021-2022 | |
| Arteriocyte Medical Systems, INC. | $43.26 | 2022 | |
| Therapeuticsmd, INC. | $39.29 | 2021 | |
| Neurocrine Biosciences, INC. | $39.12 | 2024-2025 | Ingrezza |
| Galderma Laboratories, L.P. | $26.40 | 2021-2023 | |
| Stryker Corporation | $24.85 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $22.72 | 2021 | |
| Avion Pharmaceuticals | $20.81 | 2022 | |
| Exeltis, USA INC. | $18.27 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.62 | 2022 | |
| Polarityte, INC. | $13.04 | 2019 | |
| Coopersurgical, INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hagarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.